ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,580Medicare Part D Prescriptions Filled, Including Refills

Rank: 291 out of 1206

$383K Total Retail Price of All Prescriptions

Rank: 325 out of 1206

375 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 375 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 375 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,711 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 414 370 1 2
HYDROCODONE-ACETAMINOPHEN 329 295 S3 2 7
SIMVASTATIN 327 306 3 1
OMEPRAZOLE 304 293 4 3
AMLODIPINE BESYLATE 293 278 5 6
FUROSEMIDE 231 230 6 5
FAMOTIDINE 231 180 6 65
WARFARIN SODIUM 210 206 8 8
DONEPEZIL HCL 207 205 9 29
LISINOPRIL 167 136 10 4
CITALOPRAM HBR 164 142 11 16
METOPROLOL TARTRATE 160 153 12 9
SERTRALINE HCL 147 144 13 22
MIRTAZAPINE 138 131 14 50
NAMENDA 134 132 15 36
POTASSIUM CHLORIDE 114 113 16 12
PRAVASTATIN SODIUM 104 91 17 21
QUETIAPINE FUMARATE 103 96 18 79
ATENOLOL 98 79 19 14
CIPROFLOXACIN HCL 89 81 20 61
METFORMIN HCL 89 71 20 10
ZOLPIDEM TARTRATE 84 84 22 25
PANTOPRAZOLE SODIUM 79 79 23 54
ATORVASTATIN CALCIUM 77 70 24 13
POLYETHYLENE GLYCOL 3350 76 72 25 31
TRAMADOL HCL 75 49 26 17
TRAZODONE HCL 73 58 27 37
FENTANYL 68 68 S2 28 51
FLUOXETINE HCL 67 65 29 52
ESCITALOPRAM OXALATE 64 64 30 86
PREDNISONE 62 57 31 28
SEROQUEL 61 61 32 164
FENOFIBRATE 57 55 33 56
VERAPAMIL ER 56 56 34 97
BACLOFEN 54 30 35 137
RISPERIDONE 52 40 36 74
CEPHALEXIN 51 49 37 62
CLOPIDOGREL 50 50 38 48
LOSARTAN POTASSIUM 50 47 38 20
BUSPIRONE HCL 50 50 38 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.